CoImmune Completes $45M Series A Financing Round to Advance Immuno-Oncology Pipeline
CoImmune announced the closing of a $45M Series A financing, led by Dr. Lucio Rovati, Chief Executive Officer and Chief […]
Sanofi Acquires Kiadis and Its Immuno-Oncology Assets in $359 Million Deal
Sanofi and Kiadis Pharma entered into a definitive merger agreement under which Sanofi will offer to acquire all of the […]
Sanofi Spends $360m to Accelerate Cell Therapy Drugs for Oncology & Infectious Disease
French pharmaceutical giant Sanofi has made an offer to acquire Kiadis, a clinical-stage biotech company developing what they refer to […]
OneOncology Launches OneR, a Community Oncology Research Network
OneOncology research network will enhance practices’ high-quality clinical trials programs while improving patients’ access to innovative oncology therapies. OneOncology, the […]
Mark Erlander of Cardiff Oncology, Inc. Discusses KRAS Mutations in Cancer | Podcast S2 E39
Mark Erlander, Chief Executive Officer at Cardiff Oncology, Inc. talks KRAS mutations in cancer, and existing products like mCRC, mCRPc […]
Sema4 Gives Janssen Access to Potential Competitive Advantage in Recruiting Oncology Patients
Janssen Research & Development, LLC (Janssen), a part of Johnson & Johnson, inked a partnership with a patient-centered health intelligence […]
Hexagon Bio Closes $47 million in Series A Financing to Develop Fungal-Based Oncology, Infectious Disease Therapies
Hexagon Bio announced that it has closed $47 million in Series A financing. The round was led by The Column […]
OncoImmune Closes on Series B Financing Round Worth $56 Million to Advance Oncology and Anti-Inflammatory Pipeline
OncoImmune announced the completion of a $56 million Series B financing round. The financing was co-led by HM Capital and […]
Rain Therapeutics Closes $63 Million Series B Financing Following Recent Acquisition of Two Oncology Assets
Rain Therapeutics a privately held, clinical stage biotechnology company focused on targeted therapies for patients with cancer, has closed a […]
OneOncology and Foundation Medicine Unveil First-of-its-Kind Partnership to Advance Personalized Medicine at Community Oncology Practices
Foundation Medicine, Inc. and OneOncology announced today, August 17th, 2020, a new joint initiative that is intended to better enable […]
